Summary
The motion calls for improved support and compensation for thalidomide survivors across Europe to address their growing medical and social needs. 10 15.12.2016
Other
health
human rights
social policy
Key points
- Recognition of the growing physical, emotional, and social needs of thalidomide survivors as they age.
- Identification of historical failures in drug safety monitoring and the suppression of evidence regarding side effects.
- Concerns regarding past legal irregularities that prevented manufacturers from being held fully accountable for the tragedy.
- A call for coordinated EU-wide action to create a framework for consistent compensation and assistance programs.
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.